Stock Comparison

ARGX vs MDGL

argenx NV ADR and Madrigal Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

MDGL

Madrigal Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$55.44B

$11.82B

P/E (TTM)

39.4

—

Forward P/E

34.0

666.7

Price/Sales

11.7

10.4

Price/Book

7.5

21.8

EV/EBITDA

33.9

-8.3

Dividend Yield

—

Profitability

Net Margin

31.40%

-27.30%

Operating Margin

30.00%

-29.80%

Return on Equity

20.20%

-49.30%

Return on Assets

8.86%

-17.60%

Growth (YoY)

Revenue Growth

62.60%

126.80%

Earnings Growth

114.00%

0.00%

Price & Risk

Beta

-0.0

-1.1

52-Week High

$934.62

$615.00

52-Week Low

$510.06

$284.02

Analyst Target

$1,041.14

$678.71

Compare ARGX and MDGL your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.